The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.-MedSci.cn

The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.

Roberts, HJ; Wo, JYL; Yeap, BY; Ulysse, CA; Murphy, JE; Weekes, CD; Ryan, DP; Clark, JW; Ferrone, CR; Lillemoe, KD; Qadan, M; Fernandez-del Castillo, C; Jain, RK; Hong, TS; Duda, GD

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (3):

科室
- - 订阅+
  - 更多科室
工具
服务